Skip to content

Raphael Mechoulam, PhD E-mail

Clinical Cannabis Therapeutics Series Faculty

mechoulam04Raphael Mechoulam, PhD

Professor Mechoulam, of the Hebrew University in Israel, is keynote speaker for the Sixth National Clinical Conference on Cannabis Therapeutics, April 15 - 17, 2010, in Warwick, Rhode Island. Dr. Mechoulam will speak twice at the conference:

First, the keynote speech on Friday morning, April 16th at 8:30 - Cannabis: Opening New Vistas in Both Therapy and Chemical Biology

Then, on Saturday morning, April 17th at 8:20 - Head Trauma, Osteoporosis and Alzheimer’s Disease – An Unexpected Trio

Raphael Mechoulam, PhD spoke at the Third Clincal Conference on Cannabis Therapeutics, held in Charlottesville, VA in May of 2004. His presentation is viewable in full in our on-line video series: Cannabinoid System in Neuroprotection, Raphael Mechoulam, PhD -  Dr. Mechoulam gives a brief history of Medical Cannabis, then describes the role of Cannabinoids as anti-inflammatory for arthritis, as neuroprotectant for brain injury and as a possible treatment for PTSD.discuss04

 

Photo from May of 2004, Charlottesville, VA - Professor Mechoulam in discussion with Philippe Lucas of Canada (also speaking at the 2010 conference). Looking on are Mary Lynn Mathre and Al Byrne, co-founders of Patients Out of Time. Photo by Roger Grant. 

Biography, Academic Career, Awards & Honors -  Wikipedia

Dr. Mechoulam's book, available at Amazon: 

41vobxybbl._sl160_Cannabinoids as Therapeutics, Raphael Mechoulam, PhD - In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research. - Description by Amazon
 
lidamedical university best of university universite saglik